Resources

Download 2018 Agenda

See the latest session topics and industry leading speakers on the 1.5 day agenda, with AI Applications in R&D, Clinical Trials and Moving from the ‘Science of AI’ to ‘Using AI Tools in Pharma Science

MoneyBall Medicine: AI Applications Biopharma Special Edition

Welcome to this special series of the Moneyball Medicine Podcast focused on Artificial Intelligence, Machine Learning and Analytics applied to Drug Discovery and Development.

MoneyBall Medicine: Leah Binder on How Price and Quality Transparency Helps Patients and Employers

Leapfrog Group president and CEO Leah Binder talks with Harry about data transparency and how it helps inform healthcare decisions by...

MoneyBall Medicine: John Glaser and how AI is affecting electronic medical records systems

Harry’s guest John Glaser, senior vice president of population health at Cerner, speculates on how business models in healthcare are changing and...

MoneyBall Medicine: Dekel Gelbman and how Machine Learning is changing rare disease diagnosis

Harry’s guest is Dekel Gelbman, founding CEO of FDNA. The company uses a combination of computer vision, deep learning, and...

MoneyBall Medicine: Jason Bahn and how AI and Machine Learning are enabling early disease detection

Jason Bahn, co-founder and chief medical officer of Prognos, joins Harry to talk about how machine learning is being used to dig into...

MoneyBall Medicine: Niven Narain and how AI and Machine Learning are changing drug discovery

Harry interviews Niven Narain, the co-founder, president and CEO of BERG, a Boston-based biopharma company driving the next generation of drugs and...

MoneyBall Medicine: Glenn Steele and how analytics are changing healthcare

Summit Chair, Harry Glorikian talks with Glenn Steele, chairmain of G. Steele Health Solutions and vice chairman of the Health Transformation Alliance...

Solving the Life Science Industry’s Big Data Challenge

Summit speaker, Travis McCready, President & CEO of Massachusetts Life Sciences Center on how the life science industry can solve the big data challenge

How can biopharma companies meet the challenge of attracting AI talent?

Implementing AI technologies requires a team that can span experimental science and computation...

Interview: Henry Che, Gilead Sciences

2017 Summit Attendee Henry Che, Director of R&D Information Systems, Gilead Sciences talks about the progress he and his colleagues have made on the goals they set at the 2017 Summit...

Download 2018 Event Overview

The event overview is now available to download, it includes just some of the agenda highlights you can look forward to this year, featured speakers and the top reasons to attend.

The “Why”, “How” and “When” of AI in Pharmaceutical Innovation

Last year brought about new hope and even more hype around the idea of applying artificial intelligence (AI) for “revolutionizing” drug discovery...

AI Health Matters: Biopharma Edition Newsletter

Sign up for the AI Health Matters Newsletter to receive all the latest news and developments from the AI in Biopharma movement straight to your inbox

Setting the Stage – AI Investment and Applications in the Life Sciences

There continues to be strong interest within the life science and healthcare industries on innovations that can yield new actionable insights and improve operational efficiencies. With a full spectrum of validated applications spanning multiple industries, AI promises to deliver new capabilities...

Qrativ Interview: Using AI for drug discovery without spending MORE billions

In an all-new podcast, Daniel Faggella talks to Murali Aravamudan, Founder and CEO of AI-driven drug discovery startup Qrativ, a joint venture by the Mayo Clinic and biotech/data science firm nference. Murali and Daniel discuss the surge of medical information...

How the value of data is upending traditional business models in oncology

It’s 1990: ten years before the initial sequencing of the Human Genome Project was completed. Only ten years after the first clinical use of the MRI and still more than a decade before the Health Insurance Portability and Accountability Act (HIPAA) would be enacted...